Optellum’s vision is to redefine early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way.
Our first product is the world’s first precision medicine software for early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset.
We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. Learn more at http://www.optellum.com/.